DNA -
Ginkgo Bioworks Holdin
0.7609
-0.16 (-17.29%)
As of May 10, 2024 4:00 pm EDT
Quote Detail
| Last | 0.76 |
|---|---|
| Change | -0.16 |
| Change % | -17.29 |
| Bid | 0.7797 X 2400 |
| Ask | 0.79 X 100 |
| Volume | 124.48 M |
| Shares | 2.08 B |
| Market Cap | 1.92 B |
| Open | 0.80 |
|---|---|
| High | 0.83 |
| Low | 0.72 |
| Prev Close | 0.92 |
| 52 Wk High | 2.55 |
| 52 Wk Low | 0.72 |
| EPS | -0.4347 |
| P/E | n.a. |
| Div Yield | n.a. |
Market Headlines
Ginkgo Bioworks Reports First Quarter 2024 Financial Results
BOSTON, May 9, 2024 /PRNewswire via COMTEX News Network/ -- Ginkgo announces several initiatives to accelerate path to Adjusted EBITDA breakeven by end of 2026
GreenLab Partners with Ginkgo Bioworks to Scale Up Production of Brazzein, a Novel Sweetener
JONESBORO, Ark. and BOSTON, May 7, 2024 /PRNewswire via COMTEX News Network/ -- To scale up its production of brazzein, GreenLab will leverage its proprietary technology to grow proteins inside...
Ginkgo Bioworks Announces Presentations at the Upcoming American Society of Gene & Cell Therapy (ASGCT) Annual Meeting
BOSTON, May 6, 2024 /PRNewswire via COMTEX News Network/ -- GinkgoBioworks (NYSE: DNA), which is building the leading platform for cell programming and biosecurity, today announced its...
Ginkgo Bioworks Announces Date of First Quarter 2024 Results Presentation
BOSTON, May 2, 2024 /PRNewswire via COMTEX News Network/ -- Presentation and Q&A session scheduled for post-market on Thursday, May 9, 2024
